The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis

PLSM Gordts, JD Esko - Matrix Biology, 2018 - Elsevier
Heparan sulfate proteoglycans are found at the cell surface and in the extracellular matrix,
where they interact with a plethora of proteins involved in lipid homeostasis and …

[HTML][HTML] Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid

C Hernandez, M Molusky, Y Li, S Li, JD Lin - Cell metabolism, 2010 - cell.com
Peroxisome proliferator-activated receptor (PPAR) γ coactivator-1β (PGC-1β) is a
transcriptional coactivator that induces hypertriglyceridemia in response to dietary fats …

Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice.

K Aalto-Setälä, PH Weinstock, CL Bisgaier, L Wu… - Journal of lipid …, 1996 - ASBMB
We previously showed that human apoC-III expression in transgenic mice causes
hypertriglyceridemia due to the accumulation of enlarged very low density lipoprotein …

[HTML][HTML] Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractionss⃞

Z Chunyu, K Christina, I Katsunori, FM Sacks - Journal of lipid research, 2007 - ASBMB
The atherogenicity theory for triglyceride-rich lipoproteins (TRLs; VLDL+ intermediate
density lipoprotein) generally cites the action of apolipoprotein C-III (apoC-III), a component …

[HTML][HTML] Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects

R Batal, M Tremblay, PHR Barrett, H Jacques… - Journal of lipid …, 2000 - ASBMB
Apolipoprotein (apo) C-III and apoE play a central role in controlling the plasma metabolism
of triglyceride-rich lipoproteins (TRL). We have investigated the plasma kinetics of total, very …

Apolipoprotein A-IV regulates chylomicron metabolism–mechanism and function

AB Kohan, F Wang, X Li, S Bradshaw… - American Journal …, 2012 - journals.physiology.org
Dietary fat is an important mediator of atherosclerosis and obesity. Despite its importance in
mediating metabolic disease, there is still much unknown about dietary fat absorption in the …

[HTML][HTML] Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/obMice

Z Xia, AD Sniderman, K Cianflone - Journal of Biological Chemistry, 2002 - ASBMB
Acylation-stimulating protein (ASP) acts as a paracrine signal to increase triglyceride
synthesis in adipocytes. ASP administration results in more rapid postprandial lipid …

Apolipoprotein C-III: going back to the future for a lipid drug target

MW Huff, RA Hegele - Circulation research, 2013 - Am Heart Assoc
APOA5 as the source of the association signal. 21 However, there are complex patterns of
linkage disequilibrium between common polymorphisms of APOA5 and APOC3, and it …

Lipoprotein metabolism in chronic renal insufficiency

JM Saland, HN Ginsberg - Pediatric nephrology, 2007 - Springer
Chronic renal insufficiency (CRI) is associated with a characteristic dyslipidemia. Findings in
children with CRI largely parallel those in adults. Moderate hypertriglyceridemia, increased …

[HTML][HTML] Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease

W Dai, Z Zhang, C Yao, S Zhao - Lipids in Health and Disease, 2019 - Springer
Abstract Apolipoprotein C3 (apoC3) and apolipoprotein A5 (apoA5), encoded by
APOA1/C3/A4/A5 gene cluster, are two critical regulators of plasma triglyceride (TG) …